chr10-20868749-C-G
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006393.3(NEBL):c.599G>C(p.Gly200Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,607,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G200E) has been classified as Uncertain significance.
Frequency
Consequence
NM_006393.3 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151884Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000438 AC: 11AN: 251076 AF XY: 0.0000516 show subpopulations
GnomAD4 exome AF: 0.0000261 AC: 38AN: 1455464Hom.: 0 Cov.: 30 AF XY: 0.0000317 AC XY: 23AN XY: 724566 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151884Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74158 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:2
The p.Gly200Ala variant in NEBL has been identified by our laboratory in 1 child with infantile-onset DCM and segregated with disease in 2 affected relatives. It has also been identified in 1/67606 European chromosomes by the Exome Aggrega tion Consortium (ExAC, http://exac.broadinstitute.org). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Gly200Ala variant is uncertain. -
The c.599G>C (p.G200A) alteration is located in exon 7 (coding exon 7) of the NEBL gene. This alteration results from a G to C substitution at nucleotide position 599, causing the glycine (G) at amino acid position 200 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Primary dilated cardiomyopathy Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 200 of the NEBL protein (p.Gly200Ala). This variant is present in population databases (rs727503336, gnomAD 0.02%). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 36788754). ClinVar contains an entry for this variant (Variation ID: 164763). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at